<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24442572</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>06</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1534-6269</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Current oncology reports</Title>
                <ISOAbbreviation>Curr Oncol Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The application of Oncotype DX in early-stage lymph-node-positive disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>360</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11912-013-0360-2</ELocationID>
            <Abstract>
                <AbstractText>The recurrence score derived from the 21-gene Oncotype DX assay is both prognostic and predictive of adjuvant chemotherapy benefit in node-negative, estrogen-receptor-positive breast cancer patients treated with tamoxifen. This has led to a remarkable shift in the treatment paradigm, with a sizeable number of patients being able to avoid adjuvant chemotherapy. The recurrence score was then analyzed in a large retrospective study with node-positive, estrogen-receptor-positive patients, in which it demonstrated both prognostic and predictive abilities. This review introduces the clinical trials that validated the Oncotype DX assay in the node-negative population, highlights the studies evaluating the utility of the assay in node-positive patients, examines the impact of the assay results on treatment decisions, and discusses the health outcomes and health care expenditures associated with this assay. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jain</LastName>
                    <ForeName>Sarika</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Hematology/Oncology, Department of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 N. St Clair, Suite 850, Chicago, IL, 60611, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gradishar</LastName>
                    <ForeName>William J</ForeName>
                    <Initials>WJ</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Curr Oncol Rep</MedlineTA>
            <NlmUniqueID>100888967</NlmUniqueID>
            <ISSNLinking>1523-3790</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24442572</ArticleId>
            <ArticleId IdType="doi">10.1007/s11912-013-0360-2</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2011 Apr;126(3):797-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21197567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2006 Apr 12;295(14):1658-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16609087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2010;15(5):457-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20421264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Manag Care. 2011;17(7):455-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21819166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2012 Jul 18;104(14):1068-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22767204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg. 2008 Oct;196(4):527-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18809056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res. 2006;8(3):R25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16737553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Oncol. 2009 May 1;99(6):319-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19204954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med J Aust. 2013 Aug 5;199(3):205-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23909545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Apr 1;28(10):1671-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20065191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2004 Sep 4-10;364(9437):858-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15351193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2007 Nov 20;25(33):5287-312</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17954709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2012 Mar;23(3):625-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21652577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2011 Nov;22(11):2381-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21363879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1998 Nov;16(11):3493-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9817266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Aug 10;24(23):3726-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16720680</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2013 Jun 11;108(11):2250-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23695023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2011 Sep;22 Suppl 6:vi12-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21908498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Oct 11;357(15):1496-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17928597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2005 Nov 1;23(31):8025-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16258100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2007 Mar 15;109(6):1011-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17311307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Oncol Pract. 2007 Jul;3(4):182-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20859407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2010 Jul 1;116(13):3112-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20564629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Oncol Pract. 2011 Mar;7(2):94-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21731516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Jun 12;348(24):2431-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12802030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Apr 1;28(10):1677-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20065188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2010 Jan;11(1):55-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20005174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2005 May 14-20;365(9472):1687-717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15894097</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2001 Feb 15;19(4):980-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2012 Jun;133(3):1115-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22361999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 1994 Mar;5(3):209-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8186169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2010 Jun-Jul;13(4):381-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20412544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Sep 1;26(25):4063-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18678838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Surg Oncol. 2011 Nov;18(12):3399-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21537874</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1996 Oct;14(10):2731-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8874334</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
